Bluejay Diagnostics (BJDX) Interest Expenses (2024 - 2025)

Bluejay Diagnostics' (BJDX) quarterly Interest Expenses came in at $187.0 in Q4 2025, down 74.35% year-on-year from $729.0 in Q4 2024, and down 6.5% quarter-over-quarter from $200.0 in Q3 2025.

Bluejay Diagnostics (BJDX) Interest Expenses (2024 - 2025) Analysis & Trends

Bluejay Diagnostics has disclosed Interest Expenses across 2 years of filings, most recently posting $187.0 for Q4 2025.

  • Interest Expenses for Q4 2025 came in at $187.0, down 74.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $609.0 (down 99.93% YoY), and the FY2025 annual result was $839.0, down 99.9% from the prior year.
  • Interest Expenses came in at $187.0 for Q4 2025 at Bluejay Diagnostics, down from $200.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $626471.0 in Q2 2024 to a low of $187.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 174.00 Mn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 148.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 181.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 90.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -97.17 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 96.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 15.10 Mn
10 Bluejay Diagnostics 4.43 Mn 746,549.00 - -

Historic Data

Download Data
DateValue
Dec 31, 2025 187.00
Dec 31, 2025 187.00
Sep 30, 2025 200.00
Sep 30, 2025 200.00
Jun 30, 2025 222.00
Jun 30, 2025 222.00
Dec 31, 2024 729.00
Dec 31, 2024 729.00
Sep 30, 2024 190,610.00
Sep 30, 2024 190,610.00
Jun 30, 2024 626,471.00
Jun 30, 2024 626,471.00